Home  Clinical trials Products in Development AZD3199
|
|
A number of clinical trials with AZD3199 Ongoing studies are currently in progress.
More studies will be added in due course. Additional AZD3199 Ongoing study information is available on ClinicalTrials.gov. | Study Number | Study Phase | Start Date | Recruitment Status | | D0570C00002 | Phase I | 11 Aug 2008 | Active, not recruiting | | A phase I, randomised, double-blind, placebo-controlled, parallel-group, single-centre study to investigate the safety, tolerability and pharmacokinetics of multiple ascending doses of AZD3199 (a B2-agonist) given once daily as inhaled formulation via Turbuhaler to healthy men | | D0570C00005 | Phase I | 25 Oct 2008 | Recruiting | | A phase I, randomised, double-blind, placebo-controlled, parallel-group, single-centre study to investigate the safety, tolerability and pharmacokinetics of single and multiple ascending doses of AZD3199 given once daily as inhaled formulation via Turbuhaler to Japanese healthy men | | D0570C00007 | Phase I | 11 Aug 2008 | Recruiting | | A phase II, double-blind, placebo-controlled, randomised, 6-way cross-over, single-dose study to investigate the local and systemic effects of 3 doses of inhaled AZD3199 (a β2-agonist) compared to formoterol in asthmatic patients |
|
|
|
|